On the public citation graph
Treatment of Coronary In-Stent Restenosis with a Paclitaxel-Coated Balloon Catheter
0 signed · 812 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.293.2.165openalex-snapshot
Sirolimus-Eluting Stent or Paclitaxel-Eluting Stent vs Balloon Angioplasty for Prevention of Recurrences in Patients With Coronary In-Stent Restenosis
inferredcites →https://doi.org/10.1002/ccd.20180openalex-snapshot
Sirolimus‐eluting stents for the prevention of restenosis in a worst‐case scenario of diffuse and recurrent in‐stent restenosis
inferredcites →https://doi.org/10.1002/ccd.20212openalex-snapshot
Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis
inferredcites →https://doi.org/10.1016/j.ehj.2004.02.014openalex-snapshot
Treatment of in-stent restenosis using a paclitaxel-eluting stent: acute results and long-term follow-up of a matched-pair comparison with intracoronary $beta;-radiation therapy
inferredcites →https://doi.org/10.1016/s0195-668x(03)00317-8openalex-snapshot
Contrast media as carriers for local drug delivery Successful inhibition of neointimal proliferation in the porcine coronary stent model
inferredcites →https://doi.org/10.1016/s0735-1097(02)02704-3openalex-snapshot
Sirolimus-eluting stent for treatment of complex in-stent restenosis
inferredcites →https://doi.org/10.1016/s0735-1097(03)00852-0openalex-snapshot
A randomized comparison ofrepeat stenting with balloon angioplasty in patients with in-stent restenosis
inferredcites →https://doi.org/10.1016/s0735-1097(03)01056-8openalex-snapshot
Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation
inferredcites →https://doi.org/10.1056/nejmoa012579openalex-snapshot
Intravascular Gamma Radiation for In-Stent Restenosis in Saphenous-Vein Bypass Grafts
inferredcites →https://doi.org/10.1056/nejmoa032441openalex-snapshot
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
inferredcites →https://doi.org/10.1097/01.rli.0000116125.96544.64openalex-snapshot
Inhibition of Restenosis in Stented Porcine Coronary Arteries
inferredcites →https://doi.org/10.1148/radiol.2402051248openalex-snapshot
Neointima Inhibition: Comparison of Effectiveness of Non–Stent-based Local Drug Delivery and a Drug-eluting Stent in Porcine Coronary Arteries
inferredcites →https://doi.org/10.1161/01.cir.0000060497.91775.6dopenalex-snapshot
Intracoronary Radiation Therapy Improves the Clinical and Angiographic Outcomes of Diffuse In-Stent Restenotic Lesions
inferredcites →https://doi.org/10.1161/01.cir.0000121358.26097.06openalex-snapshot
Clinical, Angiographic, and Procedural Predictors of Angiographic Restenosis After Sirolimus-Eluting Stent Implantation in Complex Patients
inferredcites →https://doi.org/10.1161/01.cir.0000127129.94129.6fopenalex-snapshot
Non–Polymer-Based Paclitaxel-Coated Coronary Stents for the Treatment of Patients With De Novo Coronary Lesions
inferredcites →https://doi.org/10.1161/01.cir.100.18.1872openalex-snapshot
Angiographic Patterns of In-Stent Restenosis
inferredcites →https://doi.org/10.1161/01.cir.101.18.2165openalex-snapshot
Intracoronary γ-Radiation Therapy After Angioplasty Inhibits Recurrence in Patients With In-Stent Restenosis
inferredcites →https://doi.org/10.1161/01.cir.94.7.1690openalex-snapshot
Marked Inflammatory Sequelae to Implantation of Biodegradable and Nonbiodegradable Polymers in Porcine Coronary Arteries
inferredcites →https://doi.org/10.1161/01.cir.96.2.636openalex-snapshot
Paclitaxel Inhibits Arterial Smooth Muscle Cell Proliferation and Migration In Vitro and In Vivo Using Local Drug Delivery
inferredcites →https://doi.org/10.1161/circulationaha105.570093openalex-snapshot
Robustness of Late Lumen Loss in Discriminating Drug-Eluting Stents Across Variable Observational and Randomized Trials
inferredcites →https://doi.org/10.1161/hc0502.103347openalex-snapshot
Rotational Atherectomy Does Not Reduce Recurrent In-Stent Restenosis
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3780134openalex-extracted
Drug-Coated Balloon and In-Stent Restenosis: A Clinical Strategy to Manage Coronary Artery Diseases
inferred← citeshttps://doi.org/10.1001/archsurg.144.1.69openalex-snapshot
Antiplatelet Agents in the Perioperative Period
inferred← citeshttps://doi.org/10.1001/jama.2024.1361openalex-snapshot
Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis
inferred← citeshttps://doi.org/10.1001/jamacardio.2024.4244openalex-snapshot
Drug-Coated Balloons for the Treatment of Coronary Artery Disease
inferred← citeshttps://doi.org/10.1002/9781118399378.ch8openalex-snapshot
Percutaneous Coronary Intervention
inferred← citeshttps://doi.org/10.1002/9781118983652.ch21openalex-snapshot
In‐Stent Restenosis in New Generation DES Era
inferred← citeshttps://doi.org/10.1002/9781119697367.ch21openalex-snapshot
In‐Stent Restenosis in the New Generation DES Era
inferred← citeshttps://doi.org/10.1002/9781444347005.ch8openalex-snapshot
Drug‐Eluting Balloons and Bifurcations, a New Future for Treatment?
inferred← citeshttps://doi.org/10.1002/9783527675869.ch8openalex-snapshot
Polyelectrolyte Multilayer Coatings for the Release and Transfer of Plasmid DNA
inferred← citeshttps://doi.org/10.1002/adem.201180067openalex-snapshot
Drug‐Coated Angioplasty Balloon Catheters: Coating Compositions and Methods
inferred← citeshttps://doi.org/10.1002/adfm.202213993openalex-snapshot
Precise Regulation of Inflammation and Oxidative Stress by ROS‐Responsive Prodrug Coated Balloon for Preventing Vascular Restenosis
inferred← citeshttps://doi.org/10.1002/adhm.202505587openalex-snapshot
Microneedle Stent for Intravascular Anchoring Effect
inferred← citeshttps://doi.org/10.1002/adrr.70121openalex-snapshot
Optimization of Magnetic Milli‐Spinner for Robotic Endovascular Intervention
inferred← citeshttps://doi.org/10.1002/bmm2.70071openalex-snapshot
Drug‐coated balloons: From conventional designs to next‐generation innovations in vascular therapy
inferred← citeshttps://doi.org/10.1002/btm2.10370openalex-snapshot
Understudied factors in drug‐coated balloon design and evaluation: A biophysical perspective
inferred← citeshttps://doi.org/10.1002/ccd.21420openalex-snapshot
Dual drug release from stents—Will we be happy with thing one and thing two?
inferred← citeshttps://doi.org/10.1002/ccd.21452openalex-snapshot
Safety and efficacy of drug‐eluting balloons in percutaneous treatment of bifurcation lesions the DEBIUT (drug‐eluting balloon in bifurcaton utrecht) registry
inferred← citeshttps://doi.org/10.1002/ccd.21475openalex-snapshot
2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention
inferred← citeshttps://doi.org/10.1002/ccd.21895openalex-snapshot
Paclitaxel‐eluting balloon: From bench to bed
inferred← citeshttps://doi.org/10.1002/ccd.21938openalex-snapshot
Treatment of drug‐eluting stent restenosis: An emerging challenge
inferred← citeshttps://doi.org/10.1002/ccd.22208openalex-snapshot
Clinical safety and efficacy of a novel thin‐strut cobalt–chromium coronary stent system: Results of the real world Coroflex Blue Registry
inferred← citeshttps://doi.org/10.1002/ccd.22468openalex-snapshot
Optimization of drug‐eluting balloon use for safety and efficacy: Evaluation of the 2nd generation paclitaxel‐eluting DIOR‐balloon in porcine coronary arteries
inferred← citeshttps://doi.org/10.1002/ccd.22856openalex-snapshot
Rationale and design of the randomized, multicenter EREMUS trial, a study that investigates how to achieve low restenosis and early reendothelialization after percutaneous coronary interventions
inferred← citeshttps://doi.org/10.1002/ccd.23256openalex-snapshot
Kissing drug eluting balloons for in‐stent restenosis complicating bifurcations treated with drug‐eluting stents
inferred← citeshttps://doi.org/10.1002/ccd.23499openalex-snapshot
A multicenter randomized comparison of drug‐eluting balloon plus bare‐metal stent versus bare‐metal stent versus drug‐eluting stent in bifurcation lesions treated with a single‐stenting technique: Six‐month angiographic and 12‐month clinical results of the drug‐eluting balloon in bifurcations trial
inferred← citeshttps://doi.org/10.1002/ccd.23502openalex-snapshot
PTCA with drug‐coated balloons is associated with immediate decrease of coronary flow reserve
inferred← citeshttps://doi.org/10.1002/ccd.24305openalex-snapshot
Long‐term effects on vascular healing of bare metal stents delivered via paclitaxel‐coated balloons in the porcine model of restenosis
inferred← citeshttps://doi.org/10.1002/ccd.24331openalex-snapshot
Local delivery of sirolimus nanoparticles for the treatment of in‐stent restenosis
inferred← citeshttps://doi.org/10.1002/ccd.24409openalex-snapshot
Paclitaxel‐coated balloon with bare‐metal stenting in patients with chronic total occlusions in native coronary arteries
inferred← citeshttps://doi.org/10.1002/ccd.24982openalex-snapshot
Experimental evaluation of pharmacokinetic profile and biological effect of a novel paclitaxel microcrystalline balloon coating in the iliofemoral territory of swine
inferred← citeshttps://doi.org/10.1002/ccd.24995openalex-snapshot
Vascular, downstream, and pharmacokinetic responses to treatment with a low dose drug‐coated balloon in a swine femoral artery model
inferred← citeshttps://doi.org/10.1002/ccd.25022openalex-snapshot
Drug‐eluting balloons for De Novo coronary artery disease
inferred← citeshttps://doi.org/10.1002/ccd.25072openalex-snapshot
Paclitaxel‐eluting balloon versus everolimus‐eluting stent for treatment of drug‐eluting stent restenosis
inferred← citeshttps://doi.org/10.1002/ccd.25149openalex-snapshot
Drug‐coated balloon treatment of coronary artery disease: A position paper of the Italian Society of Interventional Cardiology
inferred← citeshttps://doi.org/10.1002/ccd.25184openalex-snapshot
Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: Comparison with a drug eluting stent and a bare metal stent
inferred← citeshttps://doi.org/10.1002/ccd.25296openalex-snapshot
Inhibition of neo‐intimal hyperplasia in porcine coronary arteries utilizing a novel paclitaxel‐coated scoring balloon catheter
inferred← citeshttps://doi.org/10.1002/ccd.26091openalex-snapshot
Drug‐coated balloons—the importance of packing and dosing antiproliferative drugs
inferred← citeshttps://doi.org/10.1002/ccd.26216openalex-snapshot
A novel drug‐coated scoring balloon for the treatment of coronary in‐stent restenosis: Results from the multi‐center randomized controlled PATENT‐C first in human trial
inferred← citeshttps://doi.org/10.1002/ccd.26257openalex-snapshot
Fractional flow reserve‐guided paclitaxel‐coated balloon treatment for de novo coronary lesions
inferred← citeshttps://doi.org/10.1002/ccd.26451openalex-snapshot
Angiographic patterns of drug‐eluting stent restenosis after treatment with drug‐coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD‐DES study
inferred← citeshttps://doi.org/10.1002/ccd.26642openalex-snapshot
In early returns scoring scores big
inferred← citeshttps://doi.org/10.1002/ccd.26957openalex-snapshot
Drug‐coated balloons for the treatment of in‐stent restenosis in diabetic patients: A review of currently available scientific data
inferred← citeshttps://doi.org/10.1002/ccd.27688openalex-snapshot
Long‐term outcomes after treatment of bare‐metal stent restenosis with paclitaxel‐coated balloon catheters or everolimus‐eluting stents: 3‐year follow‐up of the TIS clinical study
inferred← citeshttps://doi.org/10.1002/ccd.27724openalex-snapshot
Prospective, large‐scale multicenter trial for the use of drug‐coated balloons in coronary lesions: The DCB‐only All‐Comers Registry
inferred← citeshttps://doi.org/10.1002/ccd.27996openalex-snapshot
Outcomes with drug‐coated balloons in small‐vessel coronary artery disease
inferred← citeshttps://doi.org/10.1002/ccd.29492openalex-snapshot
Procedural optimization of drug‐coated balloons in the treatment of coronary artery disease
inferred← citeshttps://doi.org/10.1002/ccd.29589openalex-snapshot
A randomized comparison of two paclitaxel‐coated balloons for the treatment of in‐stent restenosis: The LONGTY ISR China randomized trial ( LONGTY DCB vs. SeQuent Please DCB )
inferred← citeshttps://doi.org/10.1002/ccd.29640openalex-snapshot
Prognostic value of quantitative flow ratio measured immediately after d rug‐coated balloon angioplasty for in‐stent restenosis
inferred← citeshttps://doi.org/10.1002/ccd.30014openalex-snapshot
A prospective trial of a novel low‐dose paclitaxel‐coated balloon therapy in patients with restenosis in drug‐eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In‐stent REstenosis 3A (ISAR‐DESIRE 3A)
inferred← citeshttps://doi.org/10.1002/ccd.30886openalex-snapshot
Impact of prolonged drug‐coated balloon inflation on residual stenosis and clinical outcomes in coronary artery disease patients: A propensity score matched analysis
inferred← citeshttps://doi.org/10.1002/ccd.30891openalex-snapshot
The evolution and revolution of drug coated balloons in coronary angioplasty: An up‐to‐date review of literature data
inferred← citeshttps://doi.org/10.1002/ccd.31228openalex-snapshot
Comparative long‐term efficacy and safety of two paclitaxel‐coated balloons with different coating strategies for the treatment of drug‐eluting coronary stent restenosis
inferred← citeshttps://doi.org/10.1002/ccd.31266openalex-snapshot
Is the enthusiasm for Drug‐Coated balloon technology justified?
inferred← citeshttps://doi.org/10.1002/ccd.31316openalex-snapshot
Application of Drug‐Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions
inferred← citeshttps://doi.org/10.1002/ccd.31320openalex-snapshot
Cage‐Free Chronic Occlusion PCI: Multivessel Total and Subtotal Occlusion Treatment With Drug Coated Balloon Angioplasty
inferred← citeshttps://doi.org/10.1002/ccd.31388openalex-snapshot
Paclitaxel‐Coated Balloon for the Management of In‐Stent Coronary Restenosis: An Updated Meta‐Analysis and Trial Sequential Analysis
inferred← citeshttps://doi.org/10.1002/ccd.31402openalex-snapshot
Efficacy and Safety of Sirolimus‐Coated Balloon Angioplasty in De Novo Lesions in Large Coronary Vessels: A Propensity Score‐Matched Study
inferred← citeshttps://doi.org/10.1002/ccd.31699openalex-snapshot
Drug Coated Balloon in Young Patients With ST‐Elevation Myocardial Infarction: A Viable Treatment Option?
inferred← citeshttps://doi.org/10.1002/ccd.70005openalex-snapshot
Drug Coated Balloons Versus Drug‐Eluting Stents in Patients With De Novo Coronary Artery Disease
inferred← citeshttps://doi.org/10.1002/ccd.70441openalex-snapshot
Drug‐Coated Balloons Versus Drug‐Eluting Stents in Small Vessel De Novo Coronary Artery Disease: A Systematic Review and Meta‐Analysis
inferred← citeshttps://doi.org/10.1002/clc.20550openalex-snapshot
Three Year Follow‐up of the Sirolimus‐Eluting Stent and the Paclitaxel‐eluting Stent in Daily Practice
inferred← citeshttps://doi.org/10.1002/clc.22130openalex-snapshot
Cost‐Effectiveness of Paclitaxel‐Coated Balloon Angioplasty in Patients With Drug‐Eluting Stent Restenosis
inferred← citeshttps://doi.org/10.1002/clc.22942openalex-snapshot
Drug‐coated balloons for de novo lesions in small coronary arteries: rationale and design of BASKET‐SMALL 2
inferred← citeshttps://doi.org/10.1002/clc.23630openalex-snapshot
Clinical implication of quantitative flow ratio to predict clinical events after drug‐coated balloon angioplasty in patients with in‐stent restenosis
inferred← citeshttps://doi.org/10.1002/jbm.a.33136openalex-snapshot
Beneficial effects of hydrocortisone or spironolactone coating on foreign body response to mesh biomaterial in a mouse model
inferred← citeshttps://doi.org/10.1002/jps.23404openalex-snapshot
Small Molecule, Big Difference: The Role of Water in the Crystallization of Paclitaxel
inferred← citeshttps://doi.org/10.1002/wnan.154openalex-snapshot
Nanotechnology in interventional cardiology
inferred← citeshttps://doi.org/10.1007/174_2012_682openalex-snapshot
Endovascular Brachytherapy to Prevent Restenosis After Percutaneous Coronary Intervention
inferred← citeshttps://doi.org/10.1007/978-1-60327-179-0_51openalex-snapshot
Drug-Eluting Stents: A Potential Preemptive Treatment Choice for Vulnerable Coronary Plaques
inferred← citeshttps://doi.org/10.1007/978-1-61779-240-3_9openalex-snapshot
Coronary Angioplasty and Drug-Eluting Stents
inferred← citeshttps://doi.org/10.1007/978-1-62703-158-5_16openalex-snapshot
Evolving Technology in the Treatment of Peripheral Vascular Disease
inferred← citeshttps://doi.org/10.1007/978-3-031-87302-7_8openalex-snapshot
HBR in Interventional Cardiology: “The DCB Philosophy”
inferred← citeshttps://doi.org/10.1007/978-3-031-87302-7_9openalex-snapshot
Drug-Coated Balloons (DCB): Clinical Data from Registries to Randomized Trials
inferred← citeshttps://doi.org/10.1007/978-3-319-20415-4_21openalex-snapshot
What Is the Optimal Stent Design Interventionalist’s View
inferred← citeshttps://doi.org/10.1007/978-3-319-55994-0_58openalex-snapshot
In-Stent Restenosis: Definition, Entity of the Problem, Etiopathogenesis and Treatment Options
inferred← citeshttps://doi.org/10.1007/978-3-319-92600-1_1openalex-snapshot
From Drug-Eluting Balloon to Drug-Coated Balloon … to Eradication of Intracoronary Metal, a New Ending Story
inferred← citeshttps://doi.org/10.1007/978-3-319-92600-1_18openalex-snapshot
Drug-Coated Balloons: Lessons from the Real World
inferred← citeshttps://doi.org/10.1007/978-3-319-92600-1_2openalex-snapshot
History of Drug-Coated Balloons
inferred← citeshttps://doi.org/10.1007/978-3-319-92600-1_4openalex-snapshot
Local Drug Delivery to Prevent Restenosis of the Coronary and Peripheral Arteries
inferred← citeshttps://doi.org/10.1007/978-3-319-92600-1_6openalex-snapshot
Technical Insights on Drug-Coated Balloons II
inferred← citeshttps://doi.org/10.1007/978-3-319-92600-1_9openalex-snapshot
The Use of Drug-Coated Balloons for Patients with In-Stent Restenosis
inferred← citeshttps://doi.org/10.1007/978-3-540-79011-2_2openalex-snapshot
Koronare Herzkrankheit und akutes Koronarsyndrom
inferred← citeshttps://doi.org/10.1007/978-3-642-16481-1_2openalex-snapshot
Koronare Herzkrankheit und akutes Koronarsyndrom
inferred← citeshttps://doi.org/10.1007/978-3-642-25601-1_2openalex-snapshot
Prozedurale Komplikationen
inferred← citeshttps://doi.org/10.1007/978-3-662-55976-5_2openalex-snapshot
Prozedurale Komplikationen
inferred← citeshttps://doi.org/10.1007/s00059-011-3462-3openalex-snapshot
Opportunities and limitations of drug-coated balloons in interventional therapies
inferred← citeshttps://doi.org/10.1007/s00059-016-4502-9openalex-snapshot
Safety of bailout stenting after paclitaxel-coated balloon angioplasty
inferred← citeshttps://doi.org/10.1007/s00059-020-04938-8openalex-snapshot
Drug-coated balloon versus drug-eluting stent for treating de novo coronary lesions in large vessels: a meta-analysis of clinical trials
inferred← citeshttps://doi.org/10.1007/s00092-023-6204-yopenalex-snapshot
Therapie der Harnröhrenstriktur
inferred← citeshttps://doi.org/10.1007/s00104-008-1659-7openalex-snapshot
Der Patient mit Koronarstent
inferred← citeshttps://doi.org/10.1007/s00234-022-02926-9openalex-snapshot
A retrospective study of drug-coated balloon angioplasty for vertebral artery origin stenosis
inferred← citeshttps://doi.org/10.1007/s00246-011-0054-1openalex-snapshot
Serum Levels After Everolimus-Stent Implantation and Paclitaxel-Balloon Angioplasty in an Infant with Recurrent Pulmonary Vein Obstruction After Repaired Total Anomalous Pulmonary Venous Connection
inferred← citeshttps://doi.org/10.1007/s00246-017-1646-1openalex-snapshot
Drug-Coated Balloon Angioplasty: A Novel Treatment for Pulmonary Artery In-Stent Stenosis in a Patient with Williams Syndrome
inferred← citeshttps://doi.org/10.1007/s00246-025-04047-5openalex-snapshot
Drug-Eluting Balloons Versus Conventional Balloon Angioplasty for Peripheral Pulmonary Artery Stenosis in Childhood
inferred← citeshttps://doi.org/10.1007/s00270-013-0583-5openalex-snapshot
Balloon Coating with Rapamycin Using an On-site Coating Device
inferred← citeshttps://doi.org/10.1007/s00270-013-0589-zopenalex-snapshot
The Effect of Short-term Intra-arterial Delivery of Paclitaxel on Neointimal Hyperplasia and the Local Thrombotic Environment after Angioplasty
inferred← citeshttps://doi.org/10.1007/s00330-016-4354-yopenalex-snapshot
Percutaneous endovascular management of chronic superior vena cava syndrome of benign causes : long-term follow-up
inferred← citeshttps://doi.org/10.1007/s00380-015-0671-3openalex-snapshot
Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial
inferred← citeshttps://doi.org/10.1007/s00380-015-0741-6openalex-snapshot
Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation
inferred← citeshttps://doi.org/10.1007/s00380-024-02368-8openalex-snapshot
Procedural characteristics and cardiovascular outcomes in patients undergoing drug-coated balloon angioplasty for de novo lesions in large coronary arteries: an observational study
inferred← citeshttps://doi.org/10.1007/s00392-007-0548-2openalex-snapshot
Hotline Update of Clinical Trials and Registries presented at the German Cardiac Society Meeting 2007
inferred← citeshttps://doi.org/10.1007/s00392-008-0604-6openalex-snapshot
Successful local antiproliferative paclitaxel delivery in a repeatedly restenosed lesion of the right coronary artery after drug eluting-stent implantation
inferred← citeshttps://doi.org/10.1007/s00392-008-0664-7openalex-snapshot
Hotline update of clinical trials and registries presented at the German Cardiac Society meeting 2008
inferred← citeshttps://doi.org/10.1007/s00392-008-0672-7openalex-snapshot
Hotline update of clinical trials and registries presented at the ACC and SCAI-ACCi2 meeting 2008 in Chicago
inferred← citeshttps://doi.org/10.1007/s00392-008-0682-5openalex-snapshot
Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter
inferred← citeshttps://doi.org/10.1007/s00392-008-0705-2openalex-snapshot
Effect of a novel drug-eluted balloon coated with Genistein before stent implantation in porcine coronary arteries
inferred← citeshttps://doi.org/10.1007/s00392-009-0008-2openalex-snapshot
Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model
inferred← citeshttps://doi.org/10.1007/s00392-009-0101-6openalex-snapshot
Treatment of small coronary arteries with a paclitaxel-coated balloon catheter
inferred← citeshttps://doi.org/10.1007/s00392-010-0176-0openalex-snapshot
Hotlines and clinical trial updates presented at the German Cardiac Society Meeting 2010: FAIR-HF, CIPAMI, LIPSIA-NSTEMI, Handheld-BNP, PEPCAD III, remote ischaemic conditioning, CERTIFY, PreSCD-II, German Myocardial Infarction Registry, DiaRegis
inferred← citeshttps://doi.org/10.1007/s00392-011-0325-0openalex-snapshot
Hotline update of clinical trials and registries presented at the 77th spring meeting of the German Society of Cardiology 2011
inferred← citeshttps://doi.org/10.1007/s00392-011-0408-yopenalex-snapshot
Inhibition of neointimal proliferation after bare metal stent implantation with low-pressure drug delivery using a paclitaxel-coated balloon in porcine coronary arteries
inferred← citeshttps://doi.org/10.1007/s00392-012-0415-7openalex-snapshot
Inhibition of neointimal hyperplasia with a novel zotarolimus coated balloon catheter
inferred← citeshttps://doi.org/10.1007/s00392-012-0428-2openalex-snapshot
Cost-effectiveness of paclitaxel-coated balloon angioplasty and paclitaxel-eluting stent implantation for treatment of coronary in-stent restenosis in patients with stable coronary artery disease
inferred← citeshttps://doi.org/10.1007/s00392-012-0532-3openalex-snapshot
Drug-coated balloons in treatment of in-stent restenosis: a meta-analysis of randomised controlled trials
inferred← citeshttps://doi.org/10.1007/s00392-013-0556-3openalex-snapshot
Treatment of a coronary bifurcation lesion with drug-coated balloons: lumen enlargement and plaque modification after 6 months
inferred← citeshttps://doi.org/10.1007/s00392-013-0609-7openalex-snapshot
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group
inferred← citeshttps://doi.org/10.1007/s00392-013-0617-7openalex-snapshot
Compassionate use of a paclitaxel coated balloon in patients with refractory recurrent coronary in-stent restenosis
inferred← citeshttps://doi.org/10.1007/s00392-014-0775-2openalex-snapshot
Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty
inferred← citeshttps://doi.org/10.1007/s00392-015-0934-0openalex-snapshot
Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis
inferred← citeshttps://doi.org/10.1007/s00392-018-1328-xopenalex-snapshot
Percutaneous coronary intervention: balloons, stents and scaffolds
inferred← citeshttps://doi.org/10.1007/s00392-018-1346-8openalex-snapshot
Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute
inferred← citeshttps://doi.org/10.1007/s00392-021-01895-yopenalex-snapshot
Clinical outcomes of drug-coated balloon in coronary lesions: a real-world, all-comers study
inferred← citeshttps://doi.org/10.1007/s00392-023-02249-6openalex-snapshot
Sex-specific inequalities in the use of drug-coated balloons for small coronary artery disease: a report from the BASKET-SMALL 2 trial
inferred← citeshttps://doi.org/10.1007/s00392-025-02758-6openalex-snapshot
Paclitaxel-coated balloon with urea or iopromide as the excipient for treatment of coronary artery disease
inferred← citeshttps://doi.org/10.1007/s00392-025-02819-wopenalex-snapshot
Effect of vessel diameter on the clinical benefits of drug-coated balloon angioplasty: Insights from paclitaxel-coated balloon and polymer-free sirolimus-eluting stent studies
inferred← citeshttps://doi.org/10.1007/s00392-026-02957-9openalex-snapshot
Revascularization with drug-coated balloons alone in complex coronary artery disease: a systematic review
inferred← citeshttps://doi.org/10.1007/s00772-020-00713-5openalex-snapshot
Randomisierte kontrollierte Studien und Real-World-Evidence in der Marktzulassung und Überwachung von Hochrisikoprodukten – Das Beispiel Paclitaxel
inferred← citeshttps://doi.org/10.1007/s00772-020-00726-0openalex-snapshot
Randomized controlled trials and real-world evidence for market access and surveillance of high-risk products—The example of paclitaxel
inferred← citeshttps://doi.org/10.1007/s10103-019-02833-1openalex-snapshot
The effect of the debulking by excimer laser coronary angioplasty on long-term outcome compared with drug-coating balloon: insights from optical frequency domain imaging analysis
inferred← citeshttps://doi.org/10.1007/s10103-020-03019-wopenalex-snapshot
Excimer laser coronary atherectomy prior to paclitaxel-coated balloon angioplasty for de novo coronary artery lesions
inferred← citeshttps://doi.org/10.1007/s10554-019-01649-yopenalex-snapshot
Comparison of fractional flow reserve and angiographic characteristics after balloon angioplasty in de novo coronary lesions
inferred← citeshttps://doi.org/10.1007/s10554-019-01681-yopenalex-snapshot
Drug-coated balloon angioplasty: predicting outcomes based on different patterns of drug-eluting stent restenosis
inferred← citeshttps://doi.org/10.1007/s10557-016-6658-1openalex-snapshot
Paclitaxel-Coated Balloons: Investigation of Drug Transfer in Healthy and Atherosclerotic Arteries – First Experimental Results in Rabbits at Low Inflation Pressure
inferred← citeshttps://doi.org/10.1007/s10557-024-07548-2openalex-snapshot
Comparison Between Drug-Coated Balloon and Stents in Large De Novo Coronary Artery Disease: A Systematic Review and Meta-Analysis of RCT Data
inferred← citeshttps://doi.org/10.1007/s10557-024-07575-zopenalex-snapshot
Angiography-based Fractional Flow Reserve for the Prediction of Clinical Outcomes After Drug-coated Balloon or Plain Old Balloon Angioplasty
inferred← citeshttps://doi.org/10.1007/s10856-016-5737-yopenalex-snapshot
Coating of intravascular balloon with paclitaxel prevents constrictive remodeling of the dilated porcine femoral artery due to inhibition of intimal and media fibrosis
inferred← citeshttps://doi.org/10.1007/s11095-011-0643-yopenalex-snapshot
Magnetic Stents Retain Nanoparticle-Bound Antirestenotic Drugs Transported by Lipid Microbubbles
inferred← citeshttps://doi.org/10.1007/s11547-016-0680-zopenalex-snapshot
Usefulness of paclitaxel-releasing high-pressure balloon associated with cutting balloon angioplasty for treatment of outflow stenoses of failing hemodialysis arteriovenous shunts
inferred← citeshttps://doi.org/10.1007/s11789-008-0050-zopenalex-snapshot
Medikamentenbeschichteter Ballonkatheter – PACCOCATH
inferred← citeshttps://doi.org/10.1007/s11886-009-0036-6openalex-snapshot
Advances in percutaneous coronary intervention
inferred← citeshttps://doi.org/10.1007/s11886-012-0290-xopenalex-snapshot
Drug-Coated Balloons for Coronary and Peripheral Interventional Procedures
inferred← citeshttps://doi.org/10.1007/s11886-017-0823-4openalex-snapshot
Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease
inferred← citeshttps://doi.org/10.1007/s11886-018-0952-4openalex-snapshot
Therapeutic Options for In-Stent Restenosis
inferred← citeshttps://doi.org/10.1007/s11886-018-1025-4openalex-snapshot
Drug-Coated Balloons: Hope or Hot Air: Update on the Role of Coronary DCB
inferred← citeshttps://doi.org/10.1007/s11886-018-1076-6openalex-snapshot
Refractory In-Stent Restenosis: Improving Outcomes by Standardizing Our Approach
inferred← citeshttps://doi.org/10.1007/s11886-025-02249-0openalex-snapshot
In-Stent Restenosis: Incidence, Mechanisms, and Treatment Options
inferred← citeshttps://doi.org/10.1007/s11936-015-0433-7openalex-snapshot
In-Stent Restenosis: Pathophysiology and Treatment
inferred← citeshttps://doi.org/10.1007/s12181-007-0012-6openalex-snapshot
Positionspapier der DGK zur Wirksamkeit und Sicherheit von Medikamente freisetzenden Koronarstents (DES)
inferred← citeshttps://doi.org/10.1007/s12181-011-0375-6openalex-snapshot
Medikamente freisetzende Koronarstents und mit Medikamenten beschichtete Ballonkatheter
inferred← citeshttps://doi.org/10.1007/s12181-017-0202-9openalex-snapshot
Medikamentenfreisetzende Koronarstents/-scaffolds und medikamentenbeschichtete Ballonkatheter
inferred← citeshttps://doi.org/10.1007/s12181-021-00504-6openalex-snapshot
Manual der Arbeitsgruppe Interventionelle Kardiologie (AGIK) der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e.V. (DGK)
inferred← citeshttps://doi.org/10.1007/s12274-024-6979-5openalex-snapshot
Pressure-responsive pH-triggered layer-by-layer coating of paclitaxel-eluting balloon catheters for instant high-dose drug delivery for percutaneous coronary artery intervention
inferred← citeshttps://doi.org/10.1007/s12541-017-0031-6openalex-snapshot
Anti-cell adhesion characteristics of nanotextured surface for implantable biomedical device
inferred← citeshttps://doi.org/10.1007/s12928-018-0534-9openalex-snapshot
Drug-coated balloon angioplasty for de novo small vessel disease including chronic total occlusion and bifurcation in real-world clinical practice
inferred← citeshttps://doi.org/10.1007/s12928-018-0537-6openalex-snapshot
Short-term outcome of percutaneous coronary intervention with directional coronary atherectomy followed by drug-coated balloon: a preliminary report
inferred← citeshttps://doi.org/10.1007/s12928-026-01357-0openalex-snapshot
2026 revised CVIT clinical expert consensus on drug coated balloons for coronary artery disease
inferred← citeshttps://doi.org/10.1007/s13239-018-0345-2openalex-snapshot
Effect of Interstitial Fluid Flow on Drug-Coated Balloon Delivery in a Patient-Specific Arterial Vessel with Heterogeneous Tissue Composition: A Simulation Study
inferred← citeshttps://doi.org/10.1007/s13534-023-00282-yopenalex-snapshot
Histologic evaluation of a catheter coated with paclitaxel PLGA nanoparticles in the internal jugular veins of rats
inferred← citeshttps://doi.org/10.1007/s13556-013-0005-7openalex-snapshot
Evolution of Coronary Stents: From Bare-Metal Stents to Fully Biodegradable, Drug-Eluting Stents
inferred← citeshttps://doi.org/10.1007/s40435-016-0289-zopenalex-snapshot
Effect of flow pulsatility and time-dependent release kinetics on stent-based delivery through atherosclerotic plaque
inferred← citeshttps://doi.org/10.1007/s40819-016-0223-2openalex-snapshot
Effects of Interstrut Distance on the Transport of Drug and its Retention in the Arterial Tissue
inferred← citeshttps://doi.org/10.1016/b978-0-12-803963-2.50008-9openalex-snapshot
Anti-Angiogenic Therapy and Cardiovascular Diseases: Current Strategies and Future Perspectives
inferred← citeshttps://doi.org/10.1016/b978-0-12-817195-0.00028-7openalex-snapshot
Endovascular drug-delivery and drug-elution systems
inferred← citeshttps://doi.org/10.1016/b978-0-323-26219-4.00013-xopenalex-snapshot
Treatment of In-Stent Restenosis
inferred← citeshttps://doi.org/10.1016/b978-1-4377-2358-8.00013-9openalex-snapshot
Bare Metal and Drug-Eluting Coronary Stents
inferred← citeshttps://doi.org/10.1016/b978-1-4377-2358-8.00014-0openalex-snapshot
Drug-Coated Balloons
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0101-8.00011-4openalex-snapshot
Advances in Coronary Revascularization
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0764-5.00008-3openalex-snapshot
Clinical Presentation, Evaluation, and Treatment of Restenosis
inferred← citeshttps://doi.org/10.1016/j.acvd.2012.10.004openalex-snapshot
Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis
inferred← citeshttps://doi.org/10.1016/j.acvd.2017.01.005openalex-snapshot
Contemporary use of drug-coated balloons in coronary artery disease: Where are we now?
inferred← citeshttps://doi.org/10.1016/j.addr.2016.10.003openalex-snapshot
IN.PACT™ Admiral™ drug-coated balloon: Durable, consistent and safe treatment for femoropopliteal peripheral artery disease
inferred← citeshttps://doi.org/10.1016/j.addr.2017.05.015openalex-snapshot
The L utonix ® drug-coated balloon: A novel drug delivery technology for the treatment of vascular disease
inferred← citeshttps://doi.org/10.1016/j.addr.2023.114950openalex-snapshot
Solid implantable devices for sustained drug delivery
inferred← citeshttps://doi.org/10.1016/j.ahj.2007.02.023openalex-snapshot
Treatment of drug-eluting stent restenosis
inferred← citeshttps://doi.org/10.1016/j.ahj.2013.07.002openalex-snapshot
A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis
inferred← citeshttps://doi.org/10.1016/j.ahj.2017.11.008openalex-snapshot
Comparison of drug-eluting stents and drug-coated balloon for the treatment of drug-eluting coronary stent restenosis: A randomized RESTORE trial
inferred← citeshttps://doi.org/10.1016/j.ahj.2017.11.011openalex-snapshot
Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study
inferred← citeshttps://doi.org/10.1016/j.ahj.2023.01.007openalex-snapshot
Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial
inferred← citeshttps://doi.org/10.1016/j.amjcard.2013.01.073openalex-snapshot
Clinical Efficacy and Safety of Sequent Please Paclitaxel-eluting Balloon in a Real-world Multi-center Registry of South-east Asian Patients
inferred← citeshttps://doi.org/10.1016/j.amjcard.2014.01.424openalex-snapshot
Mechanisms of Postintervention and Nine-Month Luminal Enlargement After Treatment of Drug-Eluting In-Stent Restenosis With a Drug-Eluting Balloon
inferred← citeshttps://doi.org/10.1016/j.amjcard.2015.08.041openalex-snapshot
Efficacy and Safety of Paclitaxel-Coated Balloon for the Treatment of In-Stent Restenosis in High-Risk Patients
inferred← citeshttps://doi.org/10.1016/j.amjcard.2015.11.042openalex-snapshot
Comparison of the Efficacy of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With In-Stent Restenosis (from the RIBS IV and V Randomized Clinical Trials)
inferred← citeshttps://doi.org/10.1016/j.amjcard.2016.12.006openalex-snapshot
Usefulness of Drug-Eluting Balloons for Bare-Metal and Drug-Eluting In-Stent Restenosis (from the RIBS IV and V Randomized Trials)
inferred← citeshttps://doi.org/10.1016/j.amjcard.2024.07.015openalex-snapshot
Meta-Analysis Comparing Drug-Coated Balloon Versus Plain Old Balloon Angioplasty for In-Stent Restenosis of Coronary Arteries
inferred← citeshttps://doi.org/10.1016/j.amjcard.2026.02.044openalex-snapshot
Three-Year Clinical Follow-Up of a Novel Everolimus-Coated Balloon for Patients With In-Stent Restenosis
inferred← citeshttps://doi.org/10.1016/j.amjcard.2026.03.043openalex-snapshot
Sirolimus-Coated Balloon With Phospholipid Nanocarriers or Biodegradable Polymer Microspheres for Treatment of Coronary Artery Disease
inferred← citeshttps://doi.org/10.1016/j.ancard.2012.09.008openalex-snapshot
Utilisation des ballons actifs dans l’angioplastie coronaire : indications actuelles et perspectives
inferred← citeshttps://doi.org/10.1016/j.arcmed.2015.01.004openalex-snapshot
Colchicine Reduces Restenosis after Balloon Angioplasty Treatment for In-Stent Restenosis
inferred← citeshttps://doi.org/10.1016/j.carrev.2009.04.007openalex-snapshot
Percutaneous coronary intervention for small vessel coronary artery disease
inferred← citeshttps://doi.org/10.1016/j.carrev.2010.12.001openalex-snapshot
Kissing inflation is feasible with all second-generation drug-eluting balloons
inferred← citeshttps://doi.org/10.1016/j.carrev.2011.04.004openalex-snapshot
Use of a cutting balloon and a paclitaxel-coated balloon to treat recurrent subclavian in-stent restenosis causing coronary subclavian steal syndrome
showing the first 200 of 790 · page through all 790
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.